On July 28, 2017, the Vaccines and Related Biological Products Committee (VRBPAC) will meet in an open session to discuss and make recommendations on the safety and efficacy of a Hepatitis B Vaccine manufactured by Dynavax.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3r1mykM
No comments:
Post a Comment